This document is a clinical trial report published in PLoS One, detailing a study on the effects of open-label placebos on patients with irritable bowel syndrome (IBS). The study involved 80 patients and compared the effects of open-label placebo pills to a no-treatment control group. The results indicated that open-label placebos can lead to significant improvements in IBS symptoms without the need for deception. The trial was conducted at Beth Israel Deaconess Medical Center and funded by the National Center for Complementary and Alternative Medicine and The Bernard Osher Foundation.
documents/EFTA00603108.pdf
{}